Literature DB >> 17067920

International standards for tuberculosis care.

Philip C Hopewell1, Madhukar Pai, Dermot Maher, Mukund Uplekar, Mario C Raviglione.   

Abstract

Part of the reason for failing to bring about a more rapid reduction in tuberculosis incidence worldwide is the lack of effective involvement of all practitioners-public and private-in the provision of high quality tuberculosis care. While health-care providers who are part of national tuberculosis programmes have been trained and are expected to have adopted proper diagnosis, treatment, and public-health practices, the same is not likely to be true for non-programme providers. Studies of the performance of the private sector conducted in several different parts of the world suggest that poor quality care is common. The basic principles of care for people with, or suspected of having, tuberculosis are the same worldwide: a diagnosis should be established promptly; standardised treatment regimens should be used with appropriate treatment support and supervision; response to treatment should be monitored; and essential public-health responsibilities must be carried out. Prompt and accurate diagnosis, and effective treatment are essential for good patient care and tuberculosis control. All providers who undertake evaluation and treatment of patients with tuberculosis must recognise that not only are they delivering care to an individual, but they are also assuming an important public-health function. The International Standards for Tuberculosis Care (ISTC) describe a widely endorsed level of care that all practitioners should seek to achieve in managing individuals who have, or are suspected of having, tuberculosis. The document is intended to engage all care providers in delivering high quality care for patients of all ages, including those with smear-positive, smear-negative, and extra-pulmonary tuberculosis, tuberculosis caused by drug-resistant Mycobacterium tuberculosis complex, and tuberculosis combined with HIV infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17067920     DOI: 10.1016/S1473-3099(06)70628-4

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  106 in total

1.  Clinical significance of normal chest radiographs among HIV-seropositive patients with suspected tuberculosis in Uganda.

Authors:  Samuel D Yoo; Adithya Cattamanchi; Saskia Den Boon; William Worodria; Harriet Kisembo; Laurence Huang; J Lucian Davis
Journal:  Respirology       Date:  2011-07       Impact factor: 6.424

2.  Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study.

Authors:  Olga Ignatyeva; Irina Kontsevaya; Alexander Kovalyov; Yanina Balabanova; Vladislav Nikolayevskyy; Kadri Toit; Anda Dragan; Daniela Maxim; Svetlana Mironova; Tiina Kummik; Ionela Muntean; Ekaterina Koshkarova; Francis Drobniewski
Journal:  J Clin Microbiol       Date:  2012-02-29       Impact factor: 5.948

3.  Lives saved by tuberculosis control and prospects for achieving the 2015 global target for reducing tuberculosis mortality.

Authors:  Philippe Glaziou; Katherine Floyd; Eline L Korenromp; Charalambos Sismanidis; Ana L Bierrenbach; Brian G Williams; Rifat Atun; Mario Raviglione
Journal:  Bull World Health Organ       Date:  2011-05-31       Impact factor: 9.408

4.  Health-care seeking among people with cough of 2 weeks or more in India. Is passive TB case finding sufficient?

Authors:  S Satyanarayana; S A Nair; S S Chadha; G Sharma; S Yadav; S Mohanty; V Kamineni; N C Wilson; A D Harries
Journal:  Public Health Action       Date:  2012-09-21

Review 5.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Thorax       Date:  2007-08-03       Impact factor: 9.139

6.  The new Stop TB Strategy and the Global Plan to Stop TB, 2006-2015.

Authors:  Mario C Raviglione
Journal:  Bull World Health Organ       Date:  2007-05       Impact factor: 9.408

Review 7.  Multidrug-resistant to extensively drug resistant tuberculosis: what is next?

Authors:  Amita Jain; Pratima Dixit
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

8.  Diagnosis of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: Current standards and challenges.

Authors:  Giovanni Battista Migliori; Alberto Matteelli; Daniela Cirillo; Madhukar Pai
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-03       Impact factor: 2.471

9.  Autofluorescence of mycobacteria as a tool for detection of Mycobacterium tuberculosis.

Authors:  Sol Patiño; Lorenzo Alamo; Mena Cimino; Yveth Casart; Fulvia Bartoli; María J García; Leiria Salazar
Journal:  J Clin Microbiol       Date:  2008-10       Impact factor: 5.948

Review 10.  A systematic review of commercial serological antibody detection tests for the diagnosis of extrapulmonary tuberculosis.

Authors:  Karen R Steingart; Megan Henry; Suman Laal; Philip C Hopewell; Andrew Ramsay; Dick Menzies; Jane Cunningham; Karin Weldingh; Madhukar Pai
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.